3/23
08:17 am
rvph
Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering [Yahoo! Finance]
Medium
Report
Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering [Yahoo! Finance]
3/23
08:00 am
rvph
Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering
Medium
Report
Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering
3/18
10:34 pm
rvph
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering
High
Report
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering
3/18
04:10 pm
rvph
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
High
Report
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
3/5
09:00 am
rvph
Reviva Pharmaceuticals (RVPH) was downgraded by D. Boral Capital from "buy" to "hold".
Medium
Report
Reviva Pharmaceuticals (RVPH) was downgraded by D. Boral Capital from "buy" to "hold".
1/11
09:26 pm
rvph
Reviva Pharmaceuticals Holdings (RVPH) Records 37% in 2026 So far [Yahoo! Finance]
Medium
Report
Reviva Pharmaceuticals Holdings (RVPH) Records 37% in 2026 So far [Yahoo! Finance]
1/8
08:00 am
rvph
Reviva Announces Publication on Clinical Vocal Biomarker Data from the RECOVER Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia
Medium
Report
Reviva Announces Publication on Clinical Vocal Biomarker Data from the RECOVER Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia
1/5
08:33 am
rvph
Reviva Pharmaceuticals (NASDAQ:RVPH) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $2.00 price target on the stock.
Medium
Report
Reviva Pharmaceuticals (NASDAQ:RVPH) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $2.00 price target on the stock.
12/29
08:12 am
rvph
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum [Yahoo! Finance]
Medium
Report
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum [Yahoo! Finance]
12/29
08:00 am
rvph
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum
High
Report
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum
12/27
01:05 am
rvph
Reviva Pharmaceuticals (NASDAQ:RVPH) was upgraded by analysts at
Wall St
Medium
Report
Reviva Pharmaceuticals (NASDAQ:RVPH) was upgraded by analysts at
Wall St